Director of The Institute for Aging Research
Albert Einstein College of Medicine
Dr. Barzilai is a chaired Professor of Medicine and Genetics and the Director of the Institute for Aging Research at the Albert Einstein College of Medicine, which is currently the biggest Center in the world to study the Biology of Aging, and home to 2 Centers of Excellence in the Biology of Aging. He studies healthy life span in rodents by biological interventions, and also families of centenarians and several drugs are developed based, in part, on these studies. He is a recipient of Irving S. Wright Award of Distinction in Aging Research and the IPSEN Longevity award. He is founder of CohBar Inc., and leading the TAME (Targeting/Taming Aging with MEtformin) study multi central study to prove that concept that multi morbidities of aging can be delayed in humans and change the FDA indications to allow for next generation interventions.
Targeting Aging with Metformin